Restenosis and clinical outcome in patients treated with amlodipine after angioplasty: Results from the coronary angio plasty amlodipine restenosis study (CAPARES)

Journal of the American College of Cardiology

Volumn 35, Issue 3, 2000, Pages 592-599

  Jørgensen, Bjørn ^a   Simonsen, Svein ^a   Endresen, Knut ^a   Forfang, Kolbjørn ^a   Vatne, Karleif ^a   Hansen, James ^b   Webb, John ^c   Buller, Christopher ^d   Goulet, Gilles ^e   Erikssen, Jan ^f   Thaulow, Erik ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b UNIVERSITY OF CALGARY   (Canada)

^c ST PAUL S HOSPITAL   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e VANCOUVER GENERAL HOSPITAL   (Canada)

^f AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYPOCHOLESTEROLEMIC AGENT; NIFEDIPINE; PLACEBO;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; DEATH; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AMLODIPINE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CALCIUM CHANNEL BLOCKERS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; TREATMENT OUTCOME;

EID: 0034162202     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00599-9     Document Type: Article

References (48)

1. Hamon M., Bauters C., McFadden E.P., et al. Restenosis after coronary angioplasty. Eur Heart J. 16:(Suppl I):1995;33-48.
2. Boccara A., Benamer H., Juliard J.M., et al. A randomized trial of a fixed high dose vs. a weight-adjusted low dose of intravenous heparin during coronary angioplasty. Eur Heart J. 18:1997;631-635.
3. Hollman J., Simpfendorfer C., Franco I., et al. Multivessel and single-coronary angioplasty a comparative study . Am Heart J. 124:1992;9-12.
4. Lincoff A.M., Popma J.J., Ellis S.G., et al. Abrupt vessel closure complicating coronary angioplasty clinical, angiographic and therapeutic profile . J Am Coll Cardiol. 19:1992;926-935.
5. Bell R.B., Reeder G., Garratt K.N., et al. Predictors of major ischemic complications after coronary dissection following angioplasty. Am J Cardiol. 71:1993;1402-1407.
6. Kimmel S.E., Berlin J.A., Hennessy S., et al. Risk of major complications from coronary angioplasty performed immediately after diagnostic coronary angiography results from the Registry of the Society for Cardiac Angiography and Interventions . J Am Coll Cardiol. 30:1997;193-200.
7. Fischman D.L., Leon M.B., Baim D.S., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 331:1994;496-501.
8. Serruys P.W., de Jaegere P., Kiemeneji F., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 331:1994;489-495.
9. Potkin B.N., Keren G., Mintz G.S., et al. Arterial responses to arterial coronary angioplasty an intravascular ultrasound study . J Am Coll Cardiol. 20:1992;942-951.
10. Mintz G.S., Pichard A.D., Kent K.M., et al. Intravascular ultrasound comparison of restenotic and de novo coronary artery narrowings. Am J Cardiol. 74:1994;1278-1280.
11. Glagov S. Intimal hyperplasia, vascular modeling, and the restenosis problem. Circulation. 89:1994;2888-2891.
12. Landzberg B.R., Frishman W.H., Lerrick K. Pathophysiology and pharmacological approaches for prevention of coronary artery restenosis following coronary artery balloon angioplasty and related procedures. Prog Cardiovasc Dis. 39:1997;361-398.
13. Tanajura L.F., Sousa A.G., Feres F., et al. Inefficacy of diltiazem in restenosis prevention after coronary angioplasty. Arq Bras Cardiol. 62:1994;99-102.
14. Corcos T., David P.R., Val P.G., et al. Failure of diltiazem to prevent restenosis after percutaneous transluminal angioplasty. Am Heart J. 109:1985;926-931.
15. Whitworth H.B., Roubin G.S., Hollman J., et al. Effect of nifedipine on recurrent stenosis after percutaneous transluminal angioplasty. J Am Coll Cardiol. 8:1986;1271-1276.
16. Hoberg E., Schwartz F., Schömig A., et al. Prevention of restenosis by verapamil the Verapamil Angioplasty Study (VAS) . Circulation. 82:(Suppl III):1990;III-428.
17. O'Keefe J.H., Giorgi L.V., Hartzler G.O., et al. Effects of diltiazem on complications and restenosis after coronary angioplasty. Am J Cardiol. 67:1991;373-376.
18. Hillegas W.B., Ohman M., Leimberger J.D., Califf R.M. A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty. Am J Cardiol. 73:1994;835-839.
19. Greer I.A., Walker J.J., McLaren M., et al. Inhibition of whole blood aggregation by nicardipine, and synergism with prostacyclin in-vitro. Thromb Res. 41:1986;509-518.
20. Han P., Boatwright C., Ardlir N.G. Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil. Thromb Haemost. 50:1983;513-517.
21. 2 level and platelet aggregation in hypertensive patients. Arzneimittelforschung. 36:1986;1687-1689.
22. Altman R., Scazziota A., Dujovne C. Diltiazem potentiates the inhibitory effect of aspirin on platelet aggregation. Pharmacol Ther. 44:1988;320-325.
23. Nilson J., Sjölund M., Palmberg L., et al. The calcium antagonist nifedipine inhibits arterial smooth muscle cell proliferation. Atherosclerosis. 58:1985;109-122.
24. Chahine T.A., Feldman R.L., Giles T.D., et al. Randomized placebo-controlled trial of amlodipine in vasospastic angina. J Am Coll Cardiol. 21:1993;1365-1370.
25. Ueda S, Meredith PA, Howie CA, Elliott HL. A comparative assessment of the duration of amlodipine and nifedipine GITS in normotensive subjects. Br J Clin Pharmacol 1993;36:561-6.
26. Saino A., Pomidossi G., Perondi R., et al. Effects of amlodipine on coronary hemodynamics and vascular responses to sympathetic stimulation in patients with coronary heart disease. J Cardiovasc Pharmacol. 24:1994;875-882.
27. Burges R., Carter A., Gardiner D.G., Higgins A.J. Amlodipine, a new dihydropyridine calcium blocker with slow onset and long duration of action. (abstr) Br J Pharmacol. 85:1985;281P.
28. Groenschild E., Janssen J., Tijdens F. CAAS II a second generation system for off-line and on-line quantitative coronary angiography . Cathet Cardiovasc Diagn. 33:1994;61-75.
29. Serruys P.W., Foley D.P., de Feyter P.J. Quantitative Coronary Angiography in Clinical Practise. 1994;Kluwer Academic, Dordrecht, the Netherlands.
30. Beat K.J., Serruys P.W., Hugenholtz P.G. Restenosis after coronary angioplasty new standards for clinical studies . J Am Coll Cardiol. 15:1990;491-498.
31. Rensing B.J., Hermans W.R.M., Deckers J.W., et al. Lumen narrowing after percutaneous transluminal coronary balloon angioplasty follows a near gaussian distribution a quantitative angiographic study in 1,445 successfully dilated lesions . J Am Coll Cardiol. 19:1992;939-945.
32. Serruys P.W., Foley D.P., de Feyter P.J. Restenosis after coronary angioplasty a proposal of new comparative approaches based on quantitative angiography . Br Heart J. 68:1992;417-424.
33. Hoberg E., Dietz R., Frees U., et al. Verapamil treatment after coronary angioplasty in patients at high risk of recurrent stenosis. Br Heart J. 71:1994;254-260.
34. Serruys P.W., Luijten H.E., Beatt K.J., et al. Incidence of restenosis after successful angioplasty a time related phenomenon - quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months . Circulation. 77:1988;361-371.
35. Nobuyoshi M., Kimura T., Hideyuki N., et al. Restenosis after successful precutaneous coronary angioplasty serial angiographic follow-up of 229 patients . J Am Coll Cardiol. 12:1988;616-623.
36. Ip J.H., Fuster V., Israel D., et al. The role of platelets, thrombin and hyperplasia in restenosis after coronary angioplasty. J Am Coll Cardiol. 17:(Suppl B):1991;77B-88B.
37. Hollman J., Austin G.E., Gruentzig A.R., et al. Coronary artery spasm at the site of angioplasty in the first 2 months after successful PTCA. J Am Coll Cardiol. 2:1983;1039-1045.
38. Baptista J., di Mario C., Escaned J., et al. Intracoronary two-dimensional ultrasound imaging in the assessment of plaque morphologic features and the planning of coronary interventions. Am Heart J. 129:1995;177-187.
39. Andersen H.R., Mæng M., Thorwest M., Falk E. Remodelling rather than neointimal formation explains luminal narrowing after deep vessel wall injury, insights from a porcine coronary (re)stenosis model. Circulation. 93:1996;1716-1724.
40. Byington R.P., Chen J., Furberg C.D., Pitt B. Effect of amlodipine on cardiovascular events and procedures (abstr). J Am Coll Cardiol. 31:(Suppl A):1999;314A.
41. Burges D.A., Dodd M.G., Gardiner D.G. Pharmacological profile of amlodipine. Am J Cardiol. 64:(Suppl I):1989;I-101-I-120.
42. 2a and depolarization. Am J Cardiol. 64:(Suppl I):1989;I-58-I-64.
43. Garrett J.G., Farber N.E., Galen M.P. Effects of amlodipine on myocardial ischemia-reperfusion in dogs. Am J Cardiol. 64:(Suppl I):1989;I-94-I-100.
44. Hoff P.T. Cardioprotective effects of amlodipine in the ischemic-reperfused heart. Am J Cardiol. 64:(Suppl I):1989;I-101-I-116.
45. Deanfield J.E., Detry J.-M., Lichtlen P.R., et al. Amlodipine reduces myocardial ischemia in patients with coronary artery disease double-blind Circadian Anti-ischemia Program in Europe (CAPE trial) . J Am Coll Cardiol. 24:1994;1460-1467.
46. Ezekowitz M.D., Hossack K., Mehta J.L., et al. Amlodipine in chronic stable angina results of a multicenter double-blind crossover trial . Am Heart J. 129:1995;527-535.
47. Davis R.F., Habibullah H., Klinke W.P., et al. Effect of amlodipine, atenolol and their combination on myocardial ischemia during treadmill exercise and ambulatory monitoring. J Am Coll Cardiol. 25:1995;619-625.
48. Foley D.P., Bonnier H., Jackson G., et al. Prevention of restenosis after coronary balloon angioplasty rationale and design of the Fluvastatin Angioplasty REstenosis (FLARE) trial . Am J Cardiol. 73:(Suppl D):1994;50D-61D.